Karel Dolezal

This inventor holds 19 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 20 EPO patents. Top assignees: Univerzita Palackeho V Olomouci, Ustav Experimentalni Botaniky Akademie Ved Ceske Republiky, Ustav Experimentalni Botaniky Av Cr, V.v.i.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karel Dolezal. Retrieved from https://idiyas.com/inventor/karel-dolezal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 7)

% Patents Active = 42.1

CIPO Patents = 4

EPO Patents = 20 (Patent Applications = 18)

Average Co-Inventor Count = 7.5

ph-index = 3

Forward Citations = 30(Granted Patents)

Location History:

Vidce, CZ (2007 - 2013)
Olomouc, CZ (2011 - 2013)
Hlubocky, CZ (2013 - 2023)

Company Filing History:

12 out of 36

Univerzita Palackeho V Olomouci

patents

3 out of 3

Ustav Experimentalni Botaniky Akademie Ved Ceske Republiky

patents

3 out of 5

Ustav Experimentalni Botaniky Av Cr, V.v.i.

Freie Universitat Berlin

patents

7. 1 out of 1

Institute of Experimental Botany, Academy of Sciences of the Czech Republic

patent

8. 1 out of 1

Institute of Experimental Botany, Academy of Sciences of the Czeck Republic

patent

9. 1 out of 1

Univerzita Palackego V Olomouci

patent

where one patent can have more than one assignee

Years Active: 2007-2026

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570657 - Mesylate salts of heterocyclic cytokinins, compositions containing these derivatives and use thereof (2026-03-10),

2. 12378247 - Mesylate salt of para-topolin, compositions containing said salt and use thereof (2025-08-05),

3. 11643413 - 9-(2-oxacycloalkyl)-9H-purine-2,6-diamine derivatives and their use for the treatment of skin disorders (2023-05-09),

4. 10774084 - Adenine derivatives and their use as UV-photoprotective agents (2020-09-15),

5. 10662194 - Substituted 6-anilino-9-heterocyclylpurine derivatives for inhibition of plant stress (2020-05-26),

6. 10550144 - 6-aryl-9-glycosylpurines and use thereof (2020-02-04),

7. 10100077 - 6-aryl-9-glycosylpurines and use thereof (2018-10-16),

8. 10093675 - 6,8-disubstituted-9-(heterocyclyl)purines, compositions containing these derivatives and their use in cosmetic and medicinal applications (2018-10-09),

9. 9993002 - 1,2,3-thiadiazol-5yl-urea derivatives, use thereof for regulating plant senescence and preparations containing these derivatives (2018-06-12),

10. 9220269 - Use of 6-substituted 9-halogenalkyl purines for regulation of growth and development of whole plants, plant cells and plant organs; novel 6-substituted 9-halogenalkyl purines (2015-12-29),

11. 9073961 - [object Object] (2015-07-07),

12. 9023857 - Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds (2015-05-05),

13. 8575182 - 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions (2013-11-05),

14. 8552013 - [object Object] (2013-10-08),

15. 8492391 - Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives (2013-07-23),

Sure, I can help you with that. Here is an article about inventor Karel Dolezal:

Title: Innovator Spotlight: Karel Dolezal - Pioneering Advances in Biomedical Science

Introduction:

Karel Dolezal, a renowned inventor hailing from Hlubocky, CZ, is a visionary in the field of biomedical science. With an impressive count of 17 patents under his belt, Dolezal's contributions have significantly impacted the realms of pharmaceuticals and cosmetics.

Latest Patents:

Dolezal's recent patents include groundbreaking innovations such as the 9-(2-oxacycloalkyl)-9H-purine-2,6-diamine derivatives. These derivatives are heralded for their efficacy in treating a myriad of skin disorders, offering anti-aging, anti-inflammatory, and anti-neurodegenerative properties. Additionally, his work on adenine derivatives as UV-photoprotective agents showcases his dedication to developing multifaceted solutions for various industries.

Career Highlights:

Having worked with esteemed institutions like Palackeho University in Olomouci and the Institute of Experimental Botany of the Czech Academy of Sciences, Dolezal's career is marked by a commitment to pushing the boundaries of scientific exploration. His relentless pursuit of innovation has solidified his position as a trailblazer in biomedical research.

Collaborations:

Throughout his career, Dolezal has collaborated with industry stalwarts such as Miroslav Strnad and Marek Zatloukal. Together, they have spearheaded projects that have redefined industry standards and paved the way for transformative advancements in the field.

Conclusion:

In conclusion, Karel Dolezal's inventive spirit and unwavering dedication to scientific excellence have cemented his legacy as a pioneering figure in the world of biomedical innovation. His remarkable patents and collaborations stand as a testament to his enduring impact on the landscape of pharmaceuticals, cosmetics, and beyond.

Profile summary based on public USPTO records.